Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 27 April 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Effect of the GABAB agonist baclofen on symptoms of GERD

The GABAB agonist baclofen reduces 24 hour gastro-esophageal reflux and increases gastric pH in patients with GERD, finds a research team in the April issue of Gut.

News image

fiogf49gjkf04

The gamma-aminobutyric acid (GABAB) agonist baclofen reduces reflux episodes in the first 3 postprandial hours. This occurs in both patients with gastro-esophageal reflux disease (GERD) and in normal controls.

In this study, researchers from Italy assessed acute and chronic administration of baclofen on 24-hour pH metry and symptoms in GERD patients and normal controls.

In the acute study, the team assessed 28 patients with GERD, and none or mild esophagitis at endoscopy. They also assessed 15 controls.

Baclofen or placebo were administered for 24 hours in a double blinded manner.

In the acute study, gastric pH increased significantly in both groups.
Gut

Subjects underwent esophageal and gastric 48-hour pH metry.

In the chronic study, 16 GERD patients received baclofen (10 mg 4 times daily) or placebo for 4 weeks.

The team evaluated 24-hour esophageal pH metry and reflux symptom scores before and after treatment.

In the acute study, researchers found that the number of reflux episodes and percent of time with pH < 4 was significantly lower after baclofen in both GERD patients and controls.

In addition, gastric pH increased significantly in both groups.

In the chronic study, the team found that 4 weeks after initial administration of baclofen, the number of reflux episodes and percentage of time with pH < 4 significantly decreased in all GERD patients.

In addition, symptom scores significantly improved after treatment with baclofen.

Profs. Ciccaglione and Marzio concluded, "The GABAB agonist baclofen reduces 24 hour gastro-esophageal reflux and increases gastric pH in GERD patients and controls".

"When given for 1 month to GERD patients, baclofen reduces esophageal acid refluxes and significantly improves symptoms."

"Baclofen may be useful in the therapy of GERD."

Gut 2003; 52: 464-70
14 March 2003

Go to top of page Email this page Email this page to a colleague

 27 April 2017 
Esophageal endocscopic submucosal dissection
 27 April 2017 
Precision oncology in liver cancer
 27 April 2017 
Celiac disease in adolescents with susceptibility genotypes
 26 April 2017 
Time to colonoscopy and colorectal cancer
 26 April 2017 
National gastric cancer screening program
 26 April 2017 
Iron formulations for anemia in IBD
 25 April 2017 
Telemedicine tool for IBD
 25 April 2017 
Asymptomatic carriers and C. diff
 25 April 2017 
Biologics for mucosal healing in IBD
 24 April 2017 
Poor oral health and IBD
 24 April 2017 
Functional dyspepsia and duodenal eosinophilia
 24 April 2017 
Bacterial infections in cirrhosis 
 21 April 2017 
Treatment of abdominal pain in IBS 
 21 April 2017 
Improving adenoma detection rate
 21 April 2017 
Infection after living donor liver transplantation
 20 April 2017 
Diagnosis of small colorectal polyps
 20 April 2017 
Diagnosis of GERD
 20 April 2017 
Prediction of HCV vertical transmission
 19 April 2017 
Iron replacement therapy in IBD
 19 April 2017 
Heat stroke leading to acute liver failure
 19 April 2017 
Pregnancy and anti-TNF agents in IBD
 14 April 2017 
Water exchange and adenoma detection rate
 14 April 2017 
Survival in IBD associated colorectal cancer
 14 April 2017 
Tacrolimus for liver transplantation
 14 April 2017 
GastroHep.com Easter break
 13 April 2017 
Hepatic manifestations of IBD
 13 April 2017 
Multidisciplinary approach to pancreas cancer
 13 April 2017 
Predicting post-operative Crohn's recurrence
 12 April 2017 
Liver disease in patients for liver transplant
 12 April 2017 
Management of common bile duct stones
 12 April 2017 
Nucleotide analogues for Hep B and cancer risk
 11 April 2017 
Interferon-free regimens for HCV-related Child C cirrhosis
 11 April 2017 
Biodgradable stents and benign intestinal strictures
 11 April 2017 
Weight loss after nutrition training
 10 April 2017 
Polymorphisms associated with liver injury from statins
 10 April 2017 
Genetic risk factors in IBD infections
 10 April 2017 
Regimens for HCV-related Child C cirrhosis
 07 April 2017 
Transition readiness scores in adolescents with IBD
 07 April 2017 
IBD disability index
 07 April 2017 
Hepatocellular carcinoma risk in different etiologies of cirrhosis
 06 April 2017 
Antidepressants in IBD
 06 April 2017 
Meal fat content and reflux
 06 April 2017 
Hep C treatment transformation with direct antiviral agents
 05 April 2017 
Threatening life experiences in ulcerative colitis
 05 April 2017 
Prednisolone and mortality in alcoholic hepatitis 
 05 April 2017 
5-aminosalicylates and colorectal cancer in IBD
 04 April 2017 
Celiac disease in the elderly
 04 April 2017 
IBS after infectious enteritis
 04 April 2017 
Diarrhea after allogeneic stem cell transplantation
 03 April 2017 
Minorities at increased gastric cancer risk
 03 April 2017 
Incidence and risk factors of IBD
 03 April 2017 
Western diet and diverticulitis
 31 March 2017 
GI safety of direct oral anticoagulants
 31 March 2017 
Screening for celiac disease
 31 March 2017 
Low-FODMAP diet in patients with functional GI disorders
 30 March 2017 
Low-grade esophageal dysplasia and cancer risk
 30 March 2017 
Poor oral health and IBD
 30 March 2017 
Causes of villus atrophy in celiac disease without gluten
 29 March 2017 
Telemedicine in gastroenterology
 29 March 2017 
Red meat and pancreatic cancer risk

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us